Idarucizumab, a Specific Dabigatran Reversal Agent, Reduces Blood Loss in a Porcine Model of Trauma With Dabigatran Anticoagulation
Grottke, Oliver, MD, PhD, Honickel, Markus, MD, van Ryn, Joanne, PhD, ten Cate, Hugo, MD, PhD, Rossaint, Rolf, MD, Spronk, Henri M., PhD
Published in Journal of the American College of Cardiology (29.09.2015)
Published in Journal of the American College of Cardiology (29.09.2015)
Get full text
Journal Article